Marie Payton
Chief Tech/Sci/R&D Officer bij LOGICBIO THERAPEUTICS, INC.
Profiel
Marie Payton is currently the VP-Clinical Development Operations at LogicBio Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Aileron Therapeutics, Inc. She received an undergraduate degree from the University of Massachusetts and an MBA from F.W.
Olin Graduate School of Business.
Actieve functies van Marie Payton
Bedrijven | Functie | Begin |
---|---|---|
LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-04-2019 |
Eerdere bekende functies van Marie Payton
Bedrijven | Functie | Einde |
---|---|---|
AILERON THERAPEUTICS, INC. | Chief Operating Officer | - |
Opleiding van Marie Payton
University of Massachusetts | Undergraduate Degree |
F.W. Olin Graduate School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AILERON THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |